For years pharmaceutical companies and CROs have struggled to collect, clean and collate site data from disparate sources so they can make better decisions about site feasibility and selection. With the DrugDev Golden Number – a universal identifier for Investigators and sites – individual pharma companies and CROs easily match and master data, and share data across collaborations like the Investigator Databank and TransCelerate.
While the Golden Number began as a method for data sharing, innovators are using it to drive operational efficiencies, collaboration and integrated reporting as well. We expect it also will give regulators a more detailed view into the global investigator community, which ultimately can improve patient safety. Join Elisa Cascade, MBA, President DrugDev Data Solutions, for the Thursday, February 25 Breakfast Session at SCOPE and hear about the Golden Number and how it can help pharma, CROs and sites do more trials.